8.7K Views
•
09:38 min
•
August 11th, 2017
DOI :
August 11th, 2017
•Chapters in this video
0:05
Title
0:30
Determining Initial Gefitnib Concentration Using the 3-(4,5-dimethylthiazol-2-yl)-2,5- diphenylterazolium Bromide (MTT) Assay
2:15
Continuous Stepwise Dose-escalation of Gefitnib Treatment of PC-9 Cells
3:31
Determine Initial Concentration of PHA665752 Using the MTT Assay
6:37
Results: Two-step Dose-escalation Procedure to Establish Dual Resistance to EGFT-TKI and MET-TKI
8:21
Conclusion
Related Videos
Long-term High-Resolution Intravital Microscopy in the Lung with a Vacuum Stabilized Imaging Window
13.1K Views
Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models
13.6K Views
Moving Upwards: A Simple and Flexible In Vitro Three-dimensional Invasion Assay Protocol
6.0K Views
Phosphopeptide Enrichment Coupled with Label-free Quantitative Mass Spectrometry to Investigate the Phosphoproteome in Prostate Cancer
12.0K Views
Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression
16.5K Views
Mesenchymal Stem Cell Isolation from Pulp Tissue and Co-Culture with Cancer Cells to Study Their Interactions
10.2K Views
Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
7.8K Views
In Vitro Assay to Study Tumor-macrophage Interaction
7.4K Views
Radiosensitivity of Cancer Stem Cells in Lung Cancer Cell Lines
6.9K Views
In Vitro Evaluation of Oncogenic Transformation in Human Mammary Epithelial Cells
4.4K Views
Copyright © 2025 MyJoVE Corporation. All rights reserved